Nichols Weston's Form 4 filing
Cullinan Therapeutics, Inc. (CGEM) · filed Oct 21, 2025
- Accession no.
- 0000902664-25-004499
- Filed
- Oct 21, 2025, 7:00 PM ET
- Trade date
- Oct 14-17, 2025
- Filing delay
- 7 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market purchases total $2.10M. It was filed 7 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nichols WestonCIK 0001746376 | 10% Owner |
| Lynx1 Capital Management LPCIK 0001910456 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2025 | Common stock, $0.0001 par value per share ("Common Stock") | PPurchaseAcquired | +15,032 | $7.59 | +$114,047.78 | 8,564,116 | Indirect | |
| Oct 15, 2025 | Common Stock | PPurchaseAcquired | +51,500 | $7.94 | +$409,049.05 | 8,615,616 | Indirect | |
| Oct 16, 2025 | Common Stock | PPurchaseAcquired | +150,000 | $8.86 | +$1,328,250 | 8,765,616 | Indirect | |
| Oct 17, 2025 | Common Stock | PPurchaseAcquired | +32,217 | $7.84 | +$252,565.17 | 8,797,833 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.